DUBLIN, January 10, 2024 /PRNewswire/ — The “Cellulite Treatment Market Size, Share and Trends Report Analysis by Procedure Type (Non-Invasive, Minimally Invasive, Local), By Cellulite Type (Soft, Hard, Edema), By End-Use, By Region and Segment Forecasts, 2023 – 2030” reference has been added to ResearchAndMarkets.com special offer.
The global cellulite treatment market size is expected to reach 3.37 billion US dollars to 2030, registering a CAGR of 11.1% from 2023 to 2030
Increasing obesity rate worldwide and improved safety and efficacy of treatments are some of the major growth drivers for the market. The COVID-19 pandemic has adversely affected the beauty industry, including the market for cellulite treatments.
Government regulations and lockdowns in all countries have negatively affected the global economy. According to the 2020 Plastic Surgery Statistics report, approximately 86,350 cellulite treatment procedures were performed in the US. The report also showed a 24% decrease in cellulite procedures from 2019 to 2020.
Market growth is further expected to be fueled by the introduction of innovative products in the industry. For example, in January 2021, Candela Corporation announced the availability of the FDA approved Frax Pro System. It is the first platform to feature skin surfaces with Frax 1940 and Frax 1550 applicators. These applicators stimulate new collagen growth by targeting different skin layers.
In June 2020, Soliton, a medical device company, announced positive results for cellulite clinical trials. The trial looked at non-invasive 20- to 30-minute rapid pulse acoustic therapy and was applied to study the participant’s skin without the use of anesthesia. The company also said it would include the results of the study in its marketing application to the US FDA.
The market is expected to witness significant business activities such as mergers & acquisitions and strategic partnerships during the forecast period. This can be attributed to the emphasis on market consolidation by established players to limit competitive rivalry. For example, according to an article in Investor’s Business Daily, Inc., Allergan is expected to seek a partnership with Endo International for international marketing of its Endo cellulite treatment. This partnership is expected to complement Allergan’s body contouring and aesthetics portfolio.
Basic points of reference for the treatment of cellulite
- Based on procedure type, the non-invasive treatment segment accounted for the largest revenue share of 36.7% in 2022 and is expected to grow at the fastest CAGR of 11.3% during the forecast period. The increased accessibility of this procedure and ongoing research and development activities are key factors contributing to the growing popularity of this treatment.
- Based on cellulite type, soft cellulite segment accounted for the largest revenue share of 46.4% in 2022 and is expected to grow at the fastest CAGR of 11.2% during the forecast period
- On the basis of end-use, the clinics and beauty centers segment accounted for the largest revenue of 65.1% in 2022 and is expected to grow at the fastest CAGR of 11.3% during the forecast period due to the increasing occurrence of cellular and other related the aesthetic conditions
- In 2022, North America dominated the market with 35.6% share due to advanced techniques and availability of skilled professionals. Secondly, Asia Pacific expected to grow at the fastest CAGR of 12.1% during the forecast period due to lower treatment costs, increasing disposable income, and increasing prevalence of obesity
Some of the major industry players include;
- Merz Pharma
- Hologic, Inc. (Cynosure)
- Syneron Medical
- Zimmer Aesthetics
- Alma Laser
- Cymedics
- Nubway
Key topics covered:
Chapter 1. Methodology and Scope
Chapter 2. Summary
2.1. Market prospects
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cellulite Treatment Market Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.1.1. Parent market prospects
3.1.2. Related/Ancillary Market Prospects
3.2. Penetration and growth prospect mapping
3.3. Market Dynamics
3.3.1. Analysis of market drivers
3.3.2. Market Foreclosure Analysis
3.4. Cellulite Treatment Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.2. PESTEL analysis
Chapter 4. Cellulite Treatment: Estimates of Procedure Type & Trend Analysis
4.1. Cellulite Treatment Market: Key Takeaways
4.2. Cellulite Treatment Market: Trend and Market Share Analysis, 2022 & 2030
4.3. Non-invasive treatment
4.4. Minimally invasive treatment
4.5. Local treatment
Chapter 5. Cellulite Treatment: Estimates of Cellulite Types & Trend Analysis
5.1. Cellulite Treatment Market: Key Takeaways
5.3. Mild cellulite
5.4. Hard cellulite
5.5. Edema cellulitis
Chapter 6. Cellulite Treatment: End-Use Estimates & Trend Analysis
6.1. Cellulite Treatment Market: Key Takeaways
6.2. Cellulite Treatment Market: Trend and Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.4. Clinics and beauty centers
Chapter 7. Cellulite Treatment Market: Regional Estimates & Trend Analysis
7.1. Regional perspective
7.2. Cellulite Treatment Market by Region: Key Marketplace Takeaway
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, From Key Market Participants
8.2. Categorization of market participants
8.2.1. Company overview
8.2.2. Financial performance
8.2.3. Comparative evaluation of products
8.2.4. Strategic initiatives
- Merz Pharma
- Hologic, Inc. (Cynosure)
- Syneron Medical
- Zimmer Aesthetics
- Alma Laser
- Cymedics
- Nubway
For more information on this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.
Media contact:
Research and Shopping
Laura WoodSenior Manager
press@researchandmarkets.com
For EST office hours call +1-917-300-0470
For US/CAN Call Toll Free +1-800-526-8630
For GMT office hours call +353-1-416-8900
US Fax: 646-607-1907
Fax (outside USA): +353-1-481-1716
SOURCE Research and Markets
